Compare GSK plc (GSK) vs Walmart Stores Inc (WMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Walmart Stores Inc — how do they compare? GSK plc trades at $52.68 (market cap $101.34B), while Walmart Stores Inc trades at $114.96 (market cap $895.52B). The key difference: Walmart Stores Inc is far larger — about 8.8× GSK plc's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | WMT | |
|---|---|---|
Market Cap | $101.34B | $895.52B |
Sector | Health | Consumer Staples |
52-Week High | $61.18 | $134.20 |
52-Week Low | $36.20 | $95.05 |
Enterprise Value | $121.95B | $958.97B |
Dividend Yield | 3.49% | 0.88% |
Volume | — | 5,675,288 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Walmart (WMT) trades at $113.70, down 0.94% on the day, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats in recent quarters, with Q2 2026 EPS expected at $0.74. Revenue grew to $681.0B in 2025, and net income margin improved to 2.85%. Recent news highlights Walmart's AI initiatives and philanthropic efforts, while technical indicators point to near-term resistance at $115.
The outlook for WMT is positive based on robust fundamentals and analyst consensus, with a price target of $142.10 implying 25% upside. Risks include competitive pressure from Amazon and potential legal issues from recent lawsuits. Institutional sentiment remains bullish, supporting long-term growth prospects amid near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
